Company / Cash per Share
NEKTAR THERAPEUTICS Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.22
FY2025
5-year range
$0.14 / $1.22
FY2021-FY2025
Trend
+427.9%
vs FY2024
Sector context
#137 of 205
Health Care
What the data says
Cash per Share changed +428% YoY in FY2025, a notable deviation from the 9-year average annual change of +484%.
Based on SEC 10-K filings.
1.22 in FY2025 with a 5-year CAGR of +1.6%.
Improved from $0.19 to $1.22 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +36.9%
- 5-Year CAGR
- +1.6%
- 10-Year CAGR
- -
Sector benchmark
#137 of 205 in Health CareTop 67% of 205This company $1.22 Sector average $67.98
▼
-98.2% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 427.9% year-over-year.
- Ranks #137 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2018.
- Lowest cash per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -11.97 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.22 | +427.9% |
| FY2024 | $0.23 | +23.6% |
| FY2023 | $0.19 | -60.7% |
| FY2022 | $0.48 | +239.7% |
| FY2021 | $0.14 | -87.6% |
| FY2020 | $1.13 | +103.0% |
| FY2019 | $0.56 | -54.5% |
| FY2018 | $1.22 | +3831.0% |
| FY2017 | $0.03 | -66.0% |
| FY2016 | $0.09 | -78.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026